CONSTRUCTION AND CHARACTERIZATION OF NEW CLONING VEHICLES .1. AMPICILLIN-RESISTANT DERIVATIVES OF PLASMID PMB9
CONSTRUCTION AND CHARACTERIZATION OF NEW CLONING VEHICLES .1. AMPICILLIN-RESISTANT DERIVATIVES OF PLASMID PMB9
复制标题
DOI:
10.1016/0378-1119(77)90074-9
复制
发表时间:
1977-01-01
期刊:
影响因子:
3.5
通讯作者:
BOYER, HW
中科院分区:
文献类型:
--
作者:
BOLIVAR, F;RODRIGUEZ, RL;BOYER, HW
In vitro recombination via restriction endonucleases and the in vivo genetic translocation of the Ap [ampicillin] resistance (Apr) gene resulted in the construction of a new cloning vehicle, the plasmid pBR313. This vector was derived from a ColE1-like plasmid and, while it does not produce colicin E1, it still retains colicin E1 immunity. The Apr and tetracycline resistance (Tcr) markers carried in pBR313 were derived from the ampicillin transposon (TnA) of pRSF2124 and pSC101, respectively. During the construction of pBR313, the TnA component was altered and the Apr gene in pBR313 can no longer be translocated. This plasmid has a MW of 5.8 Mdalton and was characterized using 13 restriction enzymes, 6 of which (EcoRI, SmaI, HpaI, HindIII, BamHI and SalI) cleave the plasmid at unique restriction sites. This allows the molecular cloning of DNA fragments generated by these 6 enzymes. The restriction sites for the latter 3 enzymes, HindIII, BamHI and SalI, are located in the Tcr gene(s). Cloning DNA fragments into these sites alters the expression of the Tcr mechanisms thus providing a selection for [Escherichia coli] cells carrying recombinant plasmid molecules. An enrichment method for AprTcs cells carrying recombinant plasmid molecules is described.